Published in Clin Exp Immunol on November 01, 1998
B cell epitopes of gliadin. Clin Exp Immunol (2000) 1.20
Interplay between genetics and the environment in the development of celiac disease: perspectives for a healthy life. J Clin Invest (2001) 0.90
Epithelial transport and deamidation of gliadin peptides: a role for coeliac disease patient immunoglobulin A. Clin Exp Immunol (2011) 0.84
Assessing of Celiac Disease and Nonceliac Gluten Sensitivity. Gastroenterol Res Pract (2015) 0.83
IgA antibodies of coeliac disease patients recognise a dominant T cell epitope of A-gliadin. Gut (2004) 0.80
Determination of B-Cell Epitopes in Patients with Celiac Disease: Peptide Microarrays. PLoS One (2016) 0.75
Revised criteria for diagnosis of coeliac disease. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition. Arch Dis Child (1990) 8.62
Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med (1997) 7.42
Coeliac disease. II. The presence in wheat of a factor having a deleterious effect in cases of coeliac disease. Acta Paediatr (1953) 3.92
Serological markers and HLA genes among healthy first-degree relatives of patients with coeliac disease. Lancet (1991) 2.76
Evolution and heterogeneity of the alpha-/beta-type and gamma-type gliadin DNA sequences. J Biol Chem (1985) 2.19
Gliadin and reticulin antibodies in childhood coeliac disease. Lancet (1983) 2.11
Production of antiendomysial antibodies after in-vitro gliadin challenge of small intestine biopsy samples from patients with coeliac disease. Lancet (1996) 1.94
Wheat peptide challenge in coeliac disease. Lancet (1994) 1.88
Nucleic acid (cDNA) and amino acid sequences of alpha-type gliadins from wheat (Triticum aestivum). Proc Natl Acad Sci U S A (1984) 1.83
Normal small bowel biopsy followed by coeliac disease. Arch Dis Child (1990) 1.74
Intestinal antibody pattern of celiac disease: occurrence in patients with normal jejunal biopsy histology. Gastroenterology (1993) 1.61
Antigliadin and antiendomysium antibody determination for coeliac disease. Arch Dis Child (1991) 1.61
Autoantibodies in coeliac disease: tissue transglutaminase--guilt by association? Gut (1997) 1.60
Down's syndrome is strongly associated with coeliac disease. Gut (1997) 1.56
In vitro (organ culture) studies of the toxicity of specific A-gliadin peptides in celiac disease. Gastroenterology (1988) 1.42
T cells recognize a peptide derived from alpha-gliadin presented by the celiac disease-associated HLA-DQ (alpha 1*0501, beta 1*0201) heterodimer. Hum Immunol (1994) 1.37
Anti-gliadin antibodies. J Pediatr Gastroenterol Nutr (1991) 1.23
The humoral immune system in coeliac disease. Baillieres Clin Gastroenterol (1995) 1.23
Immunological diagnosis of childhood coeliac disease: comparison between antigliadin, antireticulin and antiendomysial antibodies. Clin Exp Immunol (1994) 1.21
In vitro activities of A-gliadin-related synthetic peptides: damaging effect on the atrophic coeliac mucosa and activation of mucosal immune response in the treated coeliac mucosa. Scand J Gastroenterol (1996) 1.14
Follow-up of patients positive in reticulin and gliadin antibody tests with normal small-bowel biopsy findings. Scand J Gastroenterol (1993) 1.11
In vitro toxicity of gluten peptides in coeliac disease assessed by organ culture. Scand J Gastroenterol (1995) 1.09
In vivo toxicity of a synthetic dodecapeptide from A gliadin in patients with coeliac disease. Scand J Gastroenterol (1991) 1.08
Wheat grains: a substrate for the determination of gluten antibodies in serum of gluten-sensitive patients. J Immunol Methods (1977) 1.06
High frequency of celiac disease in Down syndrome. J Pediatr (1996) 1.03
Serum and salivary antigliadin antibodies and serum IgA anti-endomysium antibodies as a screening test for coeliac disease. Acta Paediatr (1996) 0.95
Frequency and clinical pattern of celiac disease among siblings of celiac children. J Pediatr Gastroenterol Nutr (1996) 0.95
A family study of coeliac disease. Acta Paediatr Scand (1982) 0.94
IgA antigliadin antibodies in celiac and inflammatory bowel disease. J Pediatr Gastroenterol Nutr (1984) 0.90
Screening for coeliac disease in Dutch children with associated diseases. Acta Paediatr Suppl (1996) 0.88
Use of serological markers as a screening test in family members of patients with celiac disease. J Pediatr Gastroenterol Nutr (1994) 0.88
Relation between gliadin structure and coeliac toxicity. Acta Paediatr Suppl (1996) 0.87
Prevalence and clinical significance of gliadin antibodies in healthy children and adults. Scand J Gastroenterol (1994) 0.81
Identification of reactive synthetic gliadin peptides specific for coeliac disease. Int Arch Allergy Appl Immunol (1991) 0.81
Serum antibodies against gliadin and reticulin in a family study of coeliac disease. Eur J Pediatr (1980) 0.80
Anti-endomysium and anti-gliadin antibodies as serological markers for coeliac disease in childhood: a clinical study to develop a practical routine. Acta Paediatr (1995) 0.80
European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr (2012) 10.61
Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes. J Exp Med (1998) 4.65
Diagnostic approach and management of cow's-milk protein allergy in infants and children: ESPGHAN GI Committee practical guidelines. J Pediatr Gastroenterol Nutr (2012) 3.81
Isolation of CD4- CD8- mycobacteria-reactive T lymphocyte clones from rheumatoid arthritis synovial fluid. Nature (1989) 3.79
Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells. Eur J Immunol (1993) 3.73
The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. J Exp Med (2000) 3.73
Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity. J Immunol (1998) 2.88
Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling. Gut (2009) 2.50
T cell responses modulated through interaction between CD8alphaalpha and the nonclassical MHC class I molecule, TL. Science (2001) 2.30
Characterization of a cell surface-expressed disulfide-linked dimer involved in murine T cell activation. J Immunol (1988) 2.17
Identification of a T3-associated gamma delta T cell receptor on Thy-1+ dendritic epidermal Cell lines. Science (1987) 2.12
Fine specificity of the anti-citrullinated protein antibody response is influenced by the shared epitope alleles. Arthritis Rheum (2007) 2.10
Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins. J Immunol (1994) 2.07
Purification of his-tagged proteins by immobilized chelate affinity chromatography: the benefits from the use of organic solvent. Protein Expr Purif (2000) 2.00
Small intestinal T cells of celiac disease patients recognize a natural pepsin fragment of gliadin. Proc Natl Acad Sci U S A (1998) 1.99
Identification of a graft versus host disease-associated human minor histocompatibility antigen. Science (1995) 1.87
In vitro induction of human cytotoxic T lymphocyte responses against peptides of mutant and wild-type p53. Eur J Immunol (1993) 1.79
The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition. Immunity (1997) 1.78
Efficient degradation of gluten by a prolyl endoprotease in a gastrointestinal model: implications for coeliac disease. Gut (2007) 1.75
Peptide binding characteristics of the coeliac disease-associated DQ(alpha1*0501, beta1*0201) molecule. Immunogenetics (1996) 1.71
Glutenin is involved in the gluten-driven mucosal T cell response. Eur J Immunol (1999) 1.68
A mouse monoclonal antibody detecting a DR-related MT2-like specificity: serology and biochemistry. Hum Immunol (1984) 1.66
HLA-DR phenotypes in Spanish coeliac children: their contribution to the understanding of the genetics of the disease. Gut (1983) 1.65
T90/44 (9.3 antigen). A cell surface molecule with a function in human T cell activation. Eur J Immunol (1986) 1.62
KIR-ligand mismatches are associated with reduced long-term graft survival in HLA-compatible kidney transplantation. Am J Transplant (2011) 1.62
Mannose receptor-mediated uptake of antigens strongly enhances HLA class II-restricted antigen presentation by cultured dendritic cells. Eur J Immunol (1997) 1.60
Human epidermal T cells predominantly belong to the lineage expressing alpha/beta T cell receptor. J Exp Med (1990) 1.57
Identification of peptide sequences that potentially trigger HLA-A2.1-restricted cytotoxic T lymphocytes. Eur J Immunol (1993) 1.55
Accuracy and cost-effectiveness of a new strategy to screen for celiac disease in children with Down syndrome. J Pediatr (2000) 1.53
Isotype distribution of anti-cyclic citrullinated peptide antibodies in undifferentiated arthritis and rheumatoid arthritis reflects an ongoing immune response. Arthritis Rheum (2006) 1.51
Identification of major epitopes of Mycobacterium tuberculosis AG85B that are recognized by HLA-A*0201-restricted CD8+ T cells in HLA-transgenic mice and humans. J Immunol (2000) 1.48
Thy-1+ dendritic epidermal cells express T3 antigen and the T-cell receptor gamma chain. Proc Natl Acad Sci U S A (1987) 1.48
Characterization of HLA-B57-restricted human immunodeficiency virus type 1 Gag- and RT-specific cytotoxic T lymphocyte responses. J Gen Virol (1998) 1.47
CD14 contributes to the adherence of human monocytes to cytokine-stimulated endothelial cells. J Immunol (1991) 1.45
[Gluten as food additive in The Netherlands: cheese forbidden for celiac patients?]. Ned Tijdschr Geneeskd (1997) 1.40
Management guidelines of eosinophilic esophagitis in childhood. J Pediatr Gastroenterol Nutr (2014) 1.40
Specific recognition of staphylococcal enterotoxin A by human T cells bearing receptors with the V gamma 9 region. Nature (1990) 1.38
Federation of International Societies of Pediatric Gastroenterology, Hepatology, and Nutrition consensus report on celiac disease. J Pediatr Gastroenterol Nutr (2008) 1.38
Mycobacteria contain two groEL genes: the second Mycobacterium leprae groEL gene is arranged in an operon with groES. Mol Microbiol (1992) 1.28
Functional analysis of DR17(DR3)-restricted mycobacterial T cell epitopes reveals DR17-binding motif and enables the design of allele-specific competitor peptides. J Immunol (1992) 1.27
Isolation of an immunodominant viral peptide that is endogenously bound to the stress protein GP96/GRP94. Proc Natl Acad Sci U S A (1996) 1.27
Peripheral murine CD3+, CD4-, CD8- T lymphocytes express novel T cell receptor gamma delta structures. J Immunol (1988) 1.23
Identification of a novel tumor-specific CTL epitope presented by RMA, EL-4, and MBL-2 lymphomas reveals their common origin. J Immunol (2000) 1.23
DRB1*0301 molecules recognize a structural motif distinct from the one recognized by most DR beta 1 alleles. J Immunol (1992) 1.20
Health-related quality of life in children with celiac disease. J Pediatr (2001) 1.15
Systematic review: early infant feeding and the prevention of coeliac disease. Aliment Pharmacol Ther (2012) 1.15
Unique peptide binding characteristics of the disease-associated DQ(alpha 1*0501, beta 1*0201) vs the non-disease-associated DQ(alpha 1*0201, beta 1*0202) molecule. Immunogenetics (1997) 1.15
Phenotypical and functional characterization of small intestinal TcR gamma delta + T cells in coeliac disease. Scand J Immunol (1992) 1.14
HLA-DR3 molecules can bind peptides carrying two alternative specific submotifs. J Immunol (1994) 1.14
Cytomegalovirus in autoimmunity: T cell crossreactivity to viral antigen and autoantigen glutamic acid decarboxylase. Proc Natl Acad Sci U S A (2001) 1.13
The identification of CD4+ T cell epitopes with dedicated synthetic peptide libraries. Proc Natl Acad Sci U S A (1997) 1.12
Enhancement of tumor outgrowth through CTL tolerization after peptide vaccination is avoided by peptide presentation on dendritic cells. J Immunol (1998) 1.12
Dual HLA class I and class II restricted recognition of alloreactive T lymphocytes mediated by a single T cell receptor complex. Proc Natl Acad Sci U S A (2001) 1.11
Natural peptides isolated from Gly86/Val86-containing variants of HLA-DR1, -DR11, -DR13, and -DR52. Immunogenetics (1996) 1.11
An HLA class I peptide-binding assay based on competition for binding to class I molecules on intact human B cells. Identification of conserved HIV-1 polymerase peptides binding to HLA-A*0301. Hum Immunol (1995) 1.11
An iceberg of childhood coeliac disease in the Netherlands. Lancet (1999) 1.09
Specific inhibition of the classical complement pathway by C1q-binding peptides. J Immunol (2001) 1.09
Urokinase-receptor/integrin complexes are functionally involved in adhesion and progression of human breast cancer in vivo. Am J Pathol (2001) 1.08
Coordinated V gamma and V delta gene segment rearrangements in human T cell receptor gamma/delta+ lymphocytes. Eur J Immunol (1989) 1.06
Human clonal CD8 autoreactivity to an IGRP islet epitope shared between mice and men. Ann N Y Acad Sci (2007) 1.06
A computer program for predicting possible cytotoxic T lymphocyte epitopes based on HLA class I peptide-binding motifs. Hum Immunol (1995) 1.06
Identification of the core residues of the epitope of a monoclonal antibody raised against glycoprotein D of herpes simplex virus type 1 by screening of a random peptide library. Eur J Immunol (1994) 1.04
Molecular mimicry in type 1 diabetes mellitus revisited: T-cell clones to GAD65 peptides with sequence homology to Coxsackie or proinsulin peptides do not crossreact with homologous counterpart. Hum Immunol (2001) 1.04
High frequency of celiac disease in Down syndrome. J Pediatr (1996) 1.03
Effect of gluten supplementation in healthy siblings of children with celiac disease. Gastroenterology (1987) 1.03
A Leishmania homologue of receptors for activated C-kinase (LACK) induces both interferon-gamma and interleukin-10 in natural killer cells of healthy blood donors. J Infect Dis (2000) 1.02
A novel and sensitive method for the detection of T cell stimulatory epitopes of alpha/beta- and gamma-gliadin. Gut (2004) 1.01
Hypothyroidism during immunotherapy with interleukin-2 is associated with antithyroid antibodies and response to treatment. J Clin Oncol (1993) 1.01
Analogues of CTL epitopes with improved MHC class-I binding capacity elicit anti-melanoma CTL recognizing the wild-type epitope. Int J Cancer (1997) 1.01
T-cell lines reactive to an immunodominant epitope of the tyrosine phosphatase-like autoantigen IA-2 in type 1 diabetes. Diabetes (2000) 1.01
Identification of a conserved universal Th epitope in HIV-1 reverse transcriptase that is processed and presented to HIV-specific CD4+ T cells by at least four unrelated HLA-DR molecules. J Immunol (1999) 1.00
Adult height in patients with early onset of Crohn's disease. Gut (2002) 0.99
Association of smoking with the constitution of the anti-cyclic citrullinated peptide response in the absence of HLA-DRB1 shared epitope alleles. Arthritis Rheum (2007) 0.99
Endothelins: functional and autoradiographic studies in guinea pig trachea. J Pharmacol Exp Ther (1991) 0.99
Passive sexual transmission of human immunodeficiency virus type 1 variants and adaptation in new hosts. J Virol (2006) 0.98
Convenient fluorometric assay for matrix metalloproteinase activity and its application in biological media. FEBS Lett (1996) 0.98
TA10 and 2B3, two new alleles in the HLA-DQ region recognized by monoclonal antibodies. Hum Immunol (1986) 0.97
Cancer in children with celiac disease: a survey of the European Society of Paediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr (2001) 0.96
Structure of celiac disease-associated HLA-DQ8 and non-associated HLA-DQ9 alleles in complex with two disease-specific epitopes. Int Immunol (2000) 0.96
Systematic review with meta-analysis: early infant feeding and coeliac disease--update 2015. Aliment Pharmacol Ther (2015) 0.96
Identification of three non-VNTR MUC1-derived HLA-A*0201-restricted T-cell epitopes that induce protective anti-tumor immunity in HLA-A2/K(b)-transgenic mice. Int J Cancer (2001) 0.95
Anti-citrullinated protein antibodies have a low avidity compared with antibodies against recall antigens. Ann Rheum Dis (2010) 0.95
Immunization with human papillomavirus type 16 (HPV16) oncoprotein-loaded dendritic cells as well as protein in adjuvant induces MHC class I-restricted protection to HPV16-induced tumor cells. Cancer Res (1998) 0.95
HLA-DR beta chain residue 86 controls DR alpha beta dimer stability. Eur J Immunol (1993) 0.94